CONTOUR®CARE Blood Glucose Test Strips New

The CONTOUR®CARE meter and test strips are designed to help manage diabetes with ease and confidence.

Product Features

  • Compatible with the CONTOUR®CARE blood glucose meter
  • Only a tiny sample size of 0.6µL is required
  • Second-Chance® sampling allows you 30 seconds to apply more blood to the same strip if the first sample was insufficient
  • The CONTOUR®CARE blood glucose monitoring systems have demonstrated to meet all requirements of ISO 15197:2013 (EN ISO 15197:2015)*1,2

CONTOUR®CARE test strip benefits

Small amount of blood required

Small amount of blood required

Your test strip is designed to easily "sip" the blood into a sample tip. Only a small 0.6µL sample size is needed.

Second-Chance sampling

Fewer strip wastage3

Second-Chance® sampling allows you 30 seconds to apply more blood to the same strip if the first sample was insufficient.

Accurate results

Accurate results1

The CONTOUR®CARE blood glucose monitoring system has been demonstrated to meet all requirements of ISO 15197:2013 (EN ISO 15197:2015). The strips are unaffected by many common interfering substances.4

Works with

CONTOUR CARE device

CONTOUR®CARE blood glucose meter

Learn more >

FAQs

Do you have questions concerning the CONTOUR®CARE test strips? Have a look at our FAQs here.

Contact us

Would you like to know more about one of our products? Visit our contact us page.

*As confirmed by BSI Netherlands, designated as a notified body for medical devices.

1. International Organization for Standardization. In vitro diagnostic test system – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2013.
2. CONTOUR®CARE BGMS User Guide, October 2018.
3. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.
4. Brown D. et al. ePoster presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 2–5 June 2021; Virtual.